This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $2,407.72 for the supply of pharmaceutical products, including the medication Kyleena. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and is not associated with a specific set-aside designation.
The contract is a firm fixed-price delivery order with a completion date of December 18, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a wide variety of pharmaceutical products.
Generated 3/2/25, 12:47 AM